continuous glucose monitor data dexcom clarity Search Results


g7 continuous glucose monitoring device in comparison to dexcom g6 andreas pfützner1 2 3  (Dexcom Inc)
86
Dexcom Inc g7 continuous glucose monitoring device in comparison to dexcom g6 andreas pfützner1 2 3
G7 Continuous Glucose Monitoring Device In Comparison To Dexcom G6 Andreas Pfützner1 2 3, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g7 continuous glucose monitoring device in comparison to dexcom g6 andreas pfützner1 2 3/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g7 continuous glucose monitoring device in comparison to dexcom g6 andreas pfützner1 2 3 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
continuous glucose monitoring system s automated notification  (Dexcom Inc)
86
Dexcom Inc continuous glucose monitoring system s automated notification
Continuous Glucose Monitoring System S Automated Notification, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitoring system s automated notification/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
continuous glucose monitoring system s automated notification - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
glucose monitoring cgm  (Dexcom Inc)
86
Dexcom Inc glucose monitoring cgm
Glucose Monitoring Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glucose monitoring cgm/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
glucose monitoring cgm - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
glucose monitors adjusting insulin doses  (Dexcom Inc)
86
Dexcom Inc glucose monitors adjusting insulin doses
Glucose Monitors Adjusting Insulin Doses, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glucose monitors adjusting insulin doses/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
glucose monitors adjusting insulin doses - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
g6 continuous glucose monitoring cgm system  (Dexcom Inc)
86
Dexcom Inc g6 continuous glucose monitoring cgm system
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
G6 Continuous Glucose Monitoring Cgm System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6 continuous glucose monitoring cgm system/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g6 continuous glucose monitoring cgm system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
g7 continuous glucose monitoring  (Dexcom Inc)
86
Dexcom Inc g7 continuous glucose monitoring
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
G7 Continuous Glucose Monitoring, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g7 continuous glucose monitoring/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g7 continuous glucose monitoring - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
masked continuous glucose monitoring system  (Dexcom Inc)
86
Dexcom Inc masked continuous glucose monitoring system
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Masked Continuous Glucose Monitoring System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/masked continuous glucose monitoring system/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
masked continuous glucose monitoring system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
dexcom insulin pumps  (Dexcom Inc)
86
Dexcom Inc dexcom insulin pumps
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Dexcom Insulin Pumps, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dexcom insulin pumps/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
dexcom insulin pumps - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
glucose monitoring cgm device  (Dexcom Inc)
86
Dexcom Inc glucose monitoring cgm device
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Glucose Monitoring Cgm Device, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glucose monitoring cgm device/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
glucose monitoring cgm device - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
g6 continues glucose monitoring system  (Dexcom Inc)
86
Dexcom Inc g6 continues glucose monitoring system
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
G6 Continues Glucose Monitoring System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6 continues glucose monitoring system/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g6 continues glucose monitoring system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
g6 integrated continuous glucose monitoring system  (Dexcom Inc)
86
Dexcom Inc g6 integrated continuous glucose monitoring system
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
G6 Integrated Continuous Glucose Monitoring System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6 integrated continuous glucose monitoring system/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
g6 integrated continuous glucose monitoring system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
names dexcom g7 continuous glucose monitoring cgm  (Dexcom Inc)
86
Dexcom Inc names dexcom g7 continuous glucose monitoring cgm
Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom <t>G6</t> ® to Dexcom G7 ® (Day 0). Retrospective data collection: <t>CGM</t> data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.
Names Dexcom G7 Continuous Glucose Monitoring Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/names dexcom g7 continuous glucose monitoring cgm/product/Dexcom Inc
Average 86 stars, based on 1 article reviews
names dexcom g7 continuous glucose monitoring cgm - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom G6 ® to Dexcom G7 ® (Day 0). Retrospective data collection: CGM data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.

Journal: Therapeutic Advances in Endocrinology and Metabolism

Article Title: Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology

doi: 10.1177/20420188251407515

Figure Lengend Snippet: Study timeline. The schematic illustrates the study timeline, including retrospective and prospective data collection periods surrounding the transition from Dexcom G6 ® to Dexcom G7 ® (Day 0). Retrospective data collection: CGM data were retrieved at three time points before the transition (−90, −30, and −14 days), concluding the day before switching to Dexcom G7. Prospective data collection: at three time points after the transition (+14, +30, and +90 days), incorporating the day of the G7 transition in the analysis. Participants underwent two key study visits: Baseline Visit (Day 0): Included baseline questionnaires, anthropometric measurements, and HbA 1c assessment. Final Visit (+90 days): Included final questionnaires, anthropometric measurements, and HbA 1c assessment. *The day of the G7 transition is included in the prospective data downloads (+14, +30, +90). Retrospective data collection (−90, −30, −14) concludes the day before transitioning to G7. CGM, continuous glucose monitors.

Article Snippet: These functionalities have been shown to significantly improve glycemic metrics, including a 12% increase in time in range (TIR 70–180 mg/dL), reductions in mean glucose levels, a 0.38% decrease in HbA 1c , and fewer hypoglycemic episodes., Initially, the Control-IQ system was integrated with the Dexcom G6 ® continuous glucose monitoring (CGM) system, which provided real-time interstitial glucose measurements.

Techniques: